EPISODE · Jan 13, 2020 · 20 MIN
Blazing New Trails in Rare Disease & CNS Clinical Studies: An Interview with Dr. Mark Opler
from WCG Talks Trials · host WCG
In this episode, Mark Opler, PhD, MPH, Chief Research Officer at WCG MedAvante-ProPhase sits down with Steve Smith, WCG’s President of Patient Advocacy to discuss the achievements in the field of CNS and rare disease clinical research. Dr. Opler and Steve highlight the unmet need of therapies available for rare disease, the importance of patient enrollment, ensuring efficacy and safety throughout a trial, and how time is of the essence in every study that is conducted.
What this episode covers
In this episode, Mark Opler, PhD, MPH, Chief Research Officer at WCG MedAvante-ProPhase sits down with Steve Smith, WCG’s President of Patient Advocacy to discuss the achievements in the field of CNS and rare disease clinical research. Dr. Opler and Steve highlight the unmet need of therapies available for rare disease, the importance of patient enrollment, ensuring efficacy and safety throughout a trial, and how time is of the essence in every study that is conducted.
NOW PLAYING
Blazing New Trails in Rare Disease & CNS Clinical Studies: An Interview with Dr. Mark Opler
No transcript for this episode yet
Similar Episodes
Feb 8, 2026 ·26m
Jan 29, 2026 ·39m
Jan 14, 2026 ·25m
Jan 8, 2026 ·7m
Jan 7, 2026 ·45m